Summary
Promore Pharma (Promore), formerly Pergamum AB is a biopharmaceutical company that develops products based on therapeutic peptides for local and topical treatment of infections and wounds. The company’s products include LL-37, PXL01 and DPK-060. Its LL-37 is used to promote wound healing in chronic leg ulcers. Promore’s PXL01 is used to prevent scars and post-surgical adhesions. The company’s DPK-060 is used to treat skin infections in atopic dermatitis and acute external otitis. It als
Read More
- List of Tables
- Promore Pharma, Pharmaceuticals & Healthcare, Key Facts 2
- Promore Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
- Promore Pharma, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
- Promore Pharma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
- Promore Pharma, Deals By Therapy Area, 2012 to YTD 2018 8
- Promore Pharma, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
- Promore Pharma Enters into Agreement wit
Read More
- Table of Contents
- Table of Contents 3
- List of Tables 4
- List of Figures 4
- Promore Pharma, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
- Promore Pharma, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
- Promore Pharma, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
- Promore Pharma, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
- Promore Pharma, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
- Promore
Read More